RESEARCHER PROFILE
Consuelo Amantini
← Back to Università di Camerino
C
Università di Camerino
Consuelo Amantini works in Ion Channels and Receptors, Calcium signaling and nucleotide metabolism, Bladder and Urothelial Cancer Treatments, Glioma Diagnosis and Treatment, Autophagy in Disease and Therapy. Recorded institutional associations include Università di Camerino.
200Publications
13,484Citations
42H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
2016 · 5,856 citationsGuidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
2021 · 2,608 citationsCapsaicin‐induced apoptosis of glioma cells is mediated by TRPV1 vanilloid receptor and requires p38 MAPK activation
2007 · 280 citationsDanger- and pathogen-associated molecular patterns recognition by pattern-recognition receptors and ion channels of the transient receptor potential family triggers the inflammasome activation in immune cells and sensory neurons
2015 · 174 citationsCannabidiol stimulates A ml‐1a‐dependent glial differentiation and inhibits glioma stem‐like cells proliferation by inducing autophagy in a TRPV 2‐dependent manner
2015 · 154 citationsTriggering of transient receptor potential vanilloid type 1 (TRPV1) by capsaicin induces Fas/CD95-mediated apoptosis of urothelial cancer cells in an ATM-dependent manner
2009 · 152 citationsEmerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma
2013 · 150 citationsTRPV2 channel negatively controls glioma cell proliferation and resistance to Fas-induced apoptosis in ERK-dependent manner
2010 · 115 citationsTransient Receptor Potential Vanilloid Type 2 (TRPV2) Expression in Normal Urothelium and in Urothelial Carcinoma of Human Bladder: Correlation with the Pathologic Stage
2007 · 114 citationsThe role of transient receptor potential vanilloid type-2 ion channels in innate and adaptive immune responses
2013 · 101 citationsThe Effects of Cannabidiol and Prognostic Role of TRPV2 in Human Endometrial Cancer
2020 · 94 citationsUrinary Markers in Bladder Cancer: An Update
2018 · 92 citationsGuidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
2021 · 89 citationsThe transient receptor potential vanilloid‐2 cation channel impairs glioblastoma stem‐like cell proliferation and promotes differentiation
2012 · 88 citationsCannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration
2016 · 88 citationsTRPV Channels in Tumor Growth and Progression
2010 · 85 citationsCapsaicin promotes a more aggressive gene expression phenotype and invasiveness in null-TRPV1 urothelial cancer cells
2011 · 77 citations“Immuno-Transient Receptor Potential Ion Channels”: The Role in Monocyte- and Macrophage-Mediated Inflammatory Responses
2018 · 77 citationsTransient receptor potential vanilloid 1 activation induces autophagy in thymocytes through ROS-regulated AMPK and Atg4C pathways
2012 · 76 citationsPazopanib and sunitinib trigger autophagic and non-autophagic death of bladder tumour cells
2013 · 73 citationsAxitinib induces DNA damage response leading to senescence, mitotic catastrophe, and increased NK cell recognition in human renal carcinoma cells
2015 · 70 citationsEvaluations of thyme extract effects in human normal bronchial and tracheal epithelial cell lines and in human lung cancer cell line
2016 · 70 citationsICOS-L as a Potential Therapeutic Target for Cancer Immunotherapy
2018 · 69 citationsDistinct thymocyte subsets express the vanilloid receptor VR1 that mediates capsaicin-induced apoptotic cell death
2004 · 68 citationsRole of natural and adaptive immunity in renal cell carcinoma response to VEGFR‐TKIs and mTOR inhibitor
2013 · 66 citations
